Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Debt Ratio (2017 - 2025)

Aytu Biopharma (AYTU) has disclosed Debt Ratio for 14 consecutive years, with 0.1 as the latest value for Q4 2025.

  • On a quarterly basis, Debt Ratio fell 4.61% to 0.1 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.1, a 4.61% decrease, with the full-year FY2025 number at 0.1, down 8.62% from a year prior.
  • Debt Ratio was 0.1 for Q4 2025 at Aytu Biopharma, down from 0.2 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.2 in Q3 2025 to a low of 0.01 in Q4 2021.
  • A 5-year average of 0.11 and a median of 0.11 in 2023 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: crashed 91.63% in 2021, then skyrocketed 2503.38% in 2022.
  • Aytu Biopharma's Debt Ratio stood at 0.01 in 2021, then surged by 2503.38% to 0.16 in 2022, then fell by 26.32% to 0.11 in 2023, then fell by 10.97% to 0.1 in 2024, then dropped by 4.61% to 0.1 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Debt Ratio are 0.1 (Q4 2025), 0.2 (Q3 2025), and 0.1 (Q2 2025).